Adenocarcinoma, Clear Cell
"Adenocarcinoma, Clear Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)
| Descriptor ID |
D018262
|
| MeSH Number(s) |
C04.557.470.200.025.045
|
| Concept/Terms |
Adenocarcinoma, Clear Cell- Adenocarcinoma, Clear Cell
- Adenocarcinomas, Clear Cell
- Clear Cell Adenocarcinoma
- Clear Cell Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma, Clear Cell".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma, Clear Cell".
This graph shows the total number of publications written about "Adenocarcinoma, Clear Cell" by people in this website by year, and whether "Adenocarcinoma, Clear Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1996 | 0 | 1 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 3 | 0 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 3 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 3 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 3 | 6 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma, Clear Cell" by people in Profiles.
-
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283. Gynecol Oncol. 2023 09; 176:16-24.
-
Top 10 Clear Cell Head and Neck Lesions to Contemplate. Head Neck Pathol. 2023 Mar; 17(1):33-52.
-
Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. Gynecol Oncol. 2023 02; 169:164-171.
-
Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases. Am J Surg Pathol. 2022 06 01; 46(6):765-773.
-
Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma. Int J Gynecol Pathol. 2021 Mar 01; 40(2):156-164.
-
Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
-
Prenatal diethylstilbestrol exposure and cancer risk in women. Environ Mol Mutagen. 2019 06; 60(5):395-403.
-
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience. Gynecol Oncol. 2017 11; 147(2):243-249.
-
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
-
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference. J Gynecol Oncol. 2017 Jul; 28(4):e54.